These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2997067)

  • 21. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation.
    Altman R; Scazziota A; DE Lourdes Herrera M; Gonzalez C
    J Thromb Haemost; 2006 Sep; 4(9):2022-7. PubMed ID: 16961610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human endothelial cells inhibit granulocyte aggregation in vitro.
    Zimmerman GA; Klein-Knoeckel D
    J Immunol; 1986 May; 136(10):3839-47. PubMed ID: 3009611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation.
    Evangelista V; Manarini S; Dell'Elba G; Martelli N; Napoleone E; Di Santo A; Lorenzet PS
    Thromb Haemost; 2005 Sep; 94(3):568-77. PubMed ID: 16268474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.
    Judge HM; Buckland RJ; Sugidachi A; Jakubowski JA; Storey RF
    Platelets; 2008 Mar; 19(2):125-33. PubMed ID: 18297550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prothrombotic responses to exercise are little influenced by clopidogrel treatment.
    Perneby C; Wallén NH; Hu H; Li N; Hjemdahl P
    Thromb Res; 2004; 114(4):235-43. PubMed ID: 15381386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High dose corticosteroids and cell-cell interactions.
    Kjellström BT; Risberg B
    Acta Chir Scand Suppl; 1985; 526():37-47. PubMed ID: 3911707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adhesion of ADP-activated platelets to intact endothelium under stagnation point flow in vitro is mediated by the integrin alphaIIbeta3.
    Reininger AJ; Korndörfer MA; Wurzinger LJ
    Thromb Haemost; 1998 May; 79(5):998-1003. PubMed ID: 9609236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo effects of desmopressin on platelet function.
    Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
    Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endotoxin-induced platelet activation in human whole blood in vitro.
    Csako G; Suba EA; Elin RJ
    Thromb Haemost; 1988 Jun; 59(3):378-82. PubMed ID: 3055412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bubble-induced aggregation of platelets: effects of gas species, proteins, and decompression.
    Thorsen T; Klausen H; Lie RT; Holmsen H
    Undersea Hyperb Med; 1993 Jun; 20(2):101-19. PubMed ID: 8392414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists.
    Stahl GL; Morse DS; Martin SL
    Am J Physiol; 1997 Jun; 272(6 Pt 1):C1821-8. PubMed ID: 9227410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between the antiaggregating effect of ticlopidine in whole blood, platelet-rich plasma and washed platelets of the rat.
    Randon J; Lefort J; Vargaftig BB
    Thromb Res; 1982 Apr; 26(1):13-20. PubMed ID: 7048623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The involvement of polymorphonuclear leukocytes in the pathogenesis of bronchopneumonia in calves. III. Granulocyte activation by platelets.
    Ledwozyw A; Stolarczyk H
    Acta Vet Hung; 1991; 39(3-4):197-201. PubMed ID: 1664652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine.
    Renesto P; Balloy V; Vargaftig BB; Chignard M
    Br J Pharmacol; 1991 Jun; 103(2):1435-40. PubMed ID: 1653073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.
    Picard-Fraire C
    Thromb Res Suppl; 1983; 4():119-28. PubMed ID: 6356462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury.
    Siminiak T; Flores NA; Sheridan DJ
    Eur Heart J; 1995 Feb; 16(2):160-70. PubMed ID: 7744086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereospecific and non-stereospecific effects of ibuprofen on human platelet and polymorphonuclear leukocyte functions.
    Villanueva M; Heckenberger R; Palmér M; Schrör K
    Agents Actions Suppl; 1992; 37():162-70. PubMed ID: 1321554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of co-incubation and cell number of platelets and polymorphonuclear leukocytes in cellular inhibition and activation phenomena.
    Hernández R; Alemany M; Bozzo J; Ordinas A; Bastida E
    Thromb Res; 1994 May; 74(3):255-63. PubMed ID: 8042192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation by platelets of granulocyte aggregation in response to chemotaxins: studies utilizing an improved cell preparation technique.
    Redl H; Hammerschmidt DE; Schlag G
    Blood; 1983 Jan; 61(1):125-31. PubMed ID: 6848141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.